As the litigation progresses, all eyes will be on the plaintiffs legal team, led by Earles and the PSC, as they navigate the complex medical evidence, expert testimony, and legal arguments central to this landmark case
A 2022 study involving people with Irritable Bowel Syndrome (IBS) found that ROSE 010, a GLP-1 receptor agonist, reduced IBS pain during flare-ups, primarily in female participants
Several promising compounds are entering clinical trials, while existing peptides undergo refinement for improved delivery and efficacy
But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients starting body mass index, or BMI
Eliminates need for frequent injections
2007., p